Form 4: Rockwell Medical CFO Jesse Neri Reports Stock Sale
SEC Form 4
Jesse Neri, SVP, Finance and CFO of Rockwell Medical, sold 886 shares of common stock on April 1, 2025, according to a Form 4 filing.
Summary
- On April 1, 2025, Jesse Neri, the SVP, Finance and CFO of Rockwell Medical, sold 886 shares of common stock at a price of $1.1 per share.
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 13, 2024.
- Following the transaction, Neri directly owns 30,000 shares of Rockwell Medical common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company executive. It doesn't inherently convey positive or negative sentiment, as it's a routine disclosure.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.
Stakeholder Impact
- The stock sale by a company executive could be perceived negatively by some shareholders, although the use of a pre-arranged trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| 2024-12-13 | Reporting Person adopted a Rule 10b5-1 trading plan |
| 2025-04-01 | Date of stock sale transaction |
| 2025-04-02 | Date of Form 4 filing |
Keywords
Form 4, Rockwell Medical, RMTI, Jesse Neri, Stock Sale, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.